FTC said the "Big 3 PBMs" — CVS’s Caremark, Cigna’s Express Scripts, and UnitedHealth’s OptumRx — imposed markups of hundreds to thousands of percent on critical drugs, including those ...

The FTC report found that from 2017 to 2022, three PBMs—UnitedHealth Group's Optum, CVS Health's CVS Caremark and Cigna's ...

The companies say the suit is baseless and defend their practices. CVS, UnitedHealth and Cigna in October asked the FTC to disqualify Chair Linda Khan from the insulin suit, citing alleged bias ...

Cigna’s Express Scripts called the report ... what our health plans spend on medications in a year” and said the FTC had failed to address the underlying causes of rising drug prices.

It’s the latest step from pharmacy benefit managers to respond to relentless criticism from politicians and regulators over ...

Also Read: Big Pharma's Pharmacy-Benefit Managers Accuse FTC of Overreach In Effort to Reshape Drug Rebate System From 2017 to 2022, the three largest pharmacy benefit managers and their ...

All three also previously countersued the FTC, and Cigna noted that the reports are based on small subsets of data. Meanwhile, its Express Scripts PBM data shows that specialty generic medications ...

Cigna's Evernorth Health Services said on Wednesday its actions will enhance transparency about the company's negotiations.

Cigna’s Express Scripts called the report “another set of misleading conclusions based on a subset of medications that represent less than 2% of what our health plans spend on medications in a year” ...

Investing.com -- Shares of CVS Health Corp (NYSE:CVS), Cigna (NYSE:CI) Group, and UnitedHealth Group Inc (NYSE:UNH) were down around 1% after the Federal Trade Commission (FTC) accused their pharmacy ...